Supporting  and  accelerating  discovery  and  development

Supporting and accelerating discovery and development

Entrepreneurial Investing Initiative

Is your organization engaged in the discovery or development of a novel product with the potential to help patients with inflammatory bowel diseases? If so, we want to hear from you!

The Crohn's & Colitis Foundation seeks to accelerate the development of products that aim to improve the quality of life of patients with inflammatory bowel diseases. Toward that end, the Foundation is launching the Entrepreneurial Investing Initiative, a new program and dedicated funding mechanism to support product-oriented research and development. Companies and academic investigators can apply. Funding up to $500,000 per project per year will be considered. In addition, funded programs will be offered accelerator resources and advising.

For eligibility, policies, and application instructions, click here. The first step is to submit a Letter of Intent. Applicants interested in applying for the first set of awards should submit a Letter of Intent by July 21st, 2017.

Even if your organization is not interested in the Entrepreneurial Investing Initiative at this time, please consider submitting a Letter of Intent as an initial step in engaging with the Foundation. You may be eligible for additional resources, including future funding opportunities.

How to apply

Program information and application forms can be accessed and must be submitted through proposalCENTRAL.

  • Navigate to the "Grant Opportunities" tab (top right)
  • Filter by grant maker (select "Crohn's & Colitis Foundation") to find the application link for Entrepreneurial Investing

Questions? Read our FAQ, or contact Gerard Honig at entrepreneurship@crohnscolitisfoundation.org.

Connect with us at a conference!

  • June 19: Redefining Early Stage Investments Conference, San Diego
  • June 20-22: BIO International Convention, San Diego
    (Check out our presentation at 3:45PM on June 20th at the BIO Business Forum!)
  • June 27-29: Microbiome Drug Development Summit, Boston